Joshua Zeidner, Associate Professor of Medicine at the University of North Carolina at Chapel Hill, shared a post on X:
“Huge congratulations to Amir Fathi for delivering one of the most impactful plenary presentations at ASH25 in AML in the past decade. The PARADIGM study may lead to a Paradigm shift- Aza/Ven > intensive chemo in newly Dx high-risk AML.”
More posts featuring Joshua Zeidner.
